Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas

Genes Chromosomes and Cancer

Volumn 15, Issue 1, 1996, Pages 18-25

  Carbonara, Caterina ^a   Longa, Lucia ^a   Grosso, Enrico ^a   Mazzucco, Gianna ^a   Borrone, Carla ^b   Garrè, Maria Luisa ^b   Brisigotti, Massimo ^c   Filippi, Giorgio ^d   Scabar, Aldo ^d   Giannotti, Aldo ^e   Falzoni, Piero ^f   Monga, Guido ^g   Garini, Gianni ^h   Gabrielli, Marzio ^h   Riegler, Peter ⁱ   Danesino, Cesare ^j   Ruggieri, Martino ^k   Magro, Gaetano ^k   Migone, Nicola ^a,l  

^a UNIVERSITY OF TURIN   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Ospedali Civili   (Italy)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f Chirurgia Pediatrica   (Italy)

^g Anatomia Patologica   (Italy)

^h UNIVERSITY OF PARMA   (Italy)

ⁱ Ospedale Regionale   (Italy)

^j UNIVERSITY OF PAVIA   (Italy)

^k UNIVERSITY OF CATANIA   (Italy)

^l Biologia e Chimica Medica   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOMYOLIPOMA; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HAMARTOMA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; PRIORITY JOURNAL; RISK ASSESSMENT; TUBEROUS SCLEROSIS; TUMOR LOCALIZATION;

CHROMOSOME DELETION; GENES, TUMOR SUPPRESSOR; HAMARTOMA; HETEROZYGOTE; HUMANS; POLYMORPHISM, GENETIC; REPRESSOR PROTEINS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 9044220611     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7     Document Type: Article

References (32)

1. Carbonara C, Longa L, Grosso E, Borronc C, Garrè MG, Brisigotti M, Migone N (1994) 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 3:1829-1832.
2. Cheng JQ, Jhanwar SC, Lu YY, Testa JR (1993) Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res 53: 4761-4763.
3. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD (1988) Homozygous deletion of the α- and β1-interferon genes in human leukemias and derived cell lines. Proc Natl Acad Sci USA 85:5259-5263.
4. European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315.
5. Fougerousse F, Meloni R, Roudaut C, Beckmann JS (1992) Dinucleotide repeat polymorphism at the human hemoglobin alpha-1 pseudo-gene (HBAP1). Nucleic Acids Res 20:1165.
6. Fryer AE, Connor JM, Povey S, Yates J, Chalmers A, Fraser I, Yates AD, Osborne JP (1987) Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1:659-661.
7. Gomez MR (1991) Phenotypes of the tuberous sclerosis complex with a revision of the diagnostic criteria. Ann NY Acad Sci 615: 1-7.
8. Green AJ, Smith M, Yates JRW (1994a) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet 6:193-196.
9. Green AJ, Johnson PH, Yates RW (1994b) The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 10:1833-1834.
10. Gyapay G, Morisette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-94 Genethon human genetic linkage map. Nature Genet 7:246-339.
11. Jones MH, Nakamura Y (1992) Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosom Cancer 5:89-90.
12. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocken E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
13. Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJM, Short MP, Dumars K, Roach ES, Steingold S, Wall S, Blanton SH, Flodman P, Kwiatkowski DJ, Jewell A, Weber JL, Roses AD, Pericak-Vance MA (1992) Linkage of an important gene locus for tuberous sclerosis to chromosome 16 marker for polycystic kidney disease. Nature Genet 2:37-41.
14. Knudson AG (1993) Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914-10921.
15. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O (1995) A germline insertion in the tuberous sclerosis (Tsr2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nature Genet 9:70-74.
16. Kozman HM, Keith TP, Donis-Keller H, White RL, Weissenbach J, Dean M, Vergnaud G, Kidd K, Gusella J, Royle NJ, Sutherland GR, Mulley JC (1995) The CEPH consortium linkage map of human chromosome 16. Genomics 25:44-58.
17. Kwiatkowski DJ, Armour J, Bale AE, Fountain JW, Gouidie D, Aines JL, Knowles MA, Pilz A, Slaugenhaupt S, Povey S (1993) Report on the Second International Workshop on Human Chromosome 9. Cytogenet Cell Genet 64:94-103.
18. Lazaro C, Gaona A, Xu G, Weiss R, Estivill X (1993) A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet 92:429-430.
19. Maniatis TM, Fritsch EF, Sambrook J (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
20. Merlo A, Gabrielson E, Askin F, Sidransky D (1994) Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p and 6q in primary human small cell lung cancer. Cancer Res 54:640-642.
21. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
22. Northrup H, Beaudet AL, O'Brien WE, Herman GE, Lewis RA, Pollack SM (1987) Linkage of tuberous sclerosis to ABO blood group. Lancet 2:804-805.
23. Northrup H, Kwiatkowski DJ, Roach ES, Dobyns WB, Lewis RA, Herman GK, Rodriguez E, Daiger SP, Blanton SH (1992) Evidence for genetic heterogeneity in tuberous sclerosis: One locus on chromosome 9 and at least one locus elsewhere. Am J Hum Genet 51:709-720.
24. Northrup H, Wheeless JW, Bertin TK, Lewis RA (1993) Variability of expression in tuberous sclerosis. J Med Genet 30:41-43.
25. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO (1992) Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:2523-2529.
26. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO (1993) Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancer. Cancer Res 53:2410-2415.
27. Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125-127.
28. Povey S, Burley MW, Attwood J, Benham F, Hunt D, Jeremiah SJ, Franklin D, Gillet G, Malas S, Robson EB, Tippett P, Edwards JH, Kwiatkowski DJ, Super M, Mueller R, Fryer A, Clarke A, Webb D, Osborne J (1994a) Two loci for tuberous sclerosis: One on 9q34 and one on 16p13. Ann Hum Genet 58:107-127.
29. Povey S, Hurley MW, Attwood J, Benham F, Hunt D, Jeremiah SJ, Franklin D, Gillett G, Malas S, Tippett P, Edwards JH, Kwiatkowski DJ, Super M, Mueller R, Fryer A Clarke A, Webb D, Osborne J (1994b) Clinical features of TSC1 and FSC2. Ann Hum Genet 58:233-234.
30. Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L (1992) Report of the Diagnostic Criteria Committee ot the National Tuberous Sclerosis Association. J Child Neurol 7:221-224.
31. Sampson JR, Harris PC (1994) The molecular genetics of tuberous sclerosis. Hum Mol Genet 3:1477-1480.
32. Sampson JR, Yates JRW, Pirrit LA, Fleury P, Winship I, Beighton P, Connor JM (1989) Evidence for genetic heterogeneity in tuberous sclerosis. J Med Genet 26:511-516.